Gene · 8835
Papers2,451
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,451
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LncRNA SOCS2-AS1 promotes the progression of papillary thyroid cancer by destabilizing p53 protein. | Biochem Biophys Res Commun | 2023 | 37267865 | PubTator, text mining | PubMed |
| The crosstalk between FGF21 and GH leads to weakened GH receptor signaling and IGF1 expression and is associated with growth failure in very preterm infants. | Front Endocrinol (Lausanne) | 2023 | 37251684 | PubTator, text mining | PubMed |
| Smoking-Induced M2-TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5-Regulated m6A Modification of SOCS2 in NSCLC Cells. | Adv Sci (Weinh) | 2023 | 37246269 | PubTator, text mining | PubMed |
| Exosomes: Diagnostic and Therapeutic Implications in Cancer. | Pharmaceutics | 2023 | 37242707 | PubTator, text mining | PubMed |
| METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma. | Cell Commun Signal | 2023 | 37231451 | PubTator, text mining | PubMed |
| CircRNAs in osteoarthritis: research status and prospect. | Front Genet | 2023 | 37229197 | PubTator, text mining | PubMed |
| Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing. | Front Endocrinol (Lausanne) | 2023 | 37223041 | PubTator, text mining | PubMed |
| Identification of immune-related genes in acute myocardial infarction based on integrated bioinformatical methods and experimental verification. | PeerJ | 2023 | 37214088 | PubTator, text mining | PubMed |
| Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. | Signal Transduct Target Ther | 2023 | 37208335 | PubTator, text mining | PubMed |
| LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study. | Blood Adv | 2023 | 37205853 | PubTator, text mining | PubMed |
| The Ubiquitin-Proteasome System in Tumor Metabolism. | Cancers (Basel) | 2023 | 37190313 | PubTator, text mining | PubMed |
| The Roles of Antisense Long Noncoding RNAs in Tumorigenesis and Development through Cis-Regulation of Neighbouring Genes. | Biomolecules | 2023 | 37189431 | PubTator, text mining | PubMed |
| Ubiquitin-proteasome system-based signature to predict the prognosis and drug sensitivity of hepatocellular carcinoma. | Front Pharmacol | 2023 | 37180696 | PubTator, text mining | PubMed |
| Molecular Mechanisms Underlying the Progression of Aortic Valve Stenosis: Bioinformatic Analysis of Signal Pathways and Hub Genes. | Int J Mol Sci | 2023 | 37175670 | PubTator, text mining | PubMed |
| m6A modification on the fate of colorectal cancer: functions and mechanisms of cell proliferation and tumorigenesis. | Front Oncol | 2023 | 37152066 | PubTator, text mining | PubMed |
| Targeted protein degradation bypassing cereblon and von Hippel-Lindau. | Innovation (Camb) | 2023 | 37151909 | PubTator, text mining | PubMed |
| The Complex Role of HBeAg and Its Precursors in the Pathway to Hepatocellular Carcinoma. | Viruses | 2023 | 37112837 | PubTator, text mining | PubMed |
| Exploring m6A-RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome. | Pulm Circ | 2023 | 37091123 | PubTator, text mining | PubMed |
| MiR-532-3p inhibited the methylation of SOCS2 to suppress the progression of PC by targeting DNMT3A. | Life Sci Alliance | 2023 | 37085288 | PubTator, text mining | PubMed |
| METTL3 Mediates Epithelial-Mesenchymal Transition by Modulating FOXO1 mRNA N6 -Methyladenosine-Dependent YTHDF2 Binding: A Novel Mechanism of Radiation-Induced Lung Injury. | Adv Sci (Weinh) | 2023 | 37072646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8835/papers?page=14